Pharma & Bio

Latest Content

Editor's comment

'Interesting times' beckon for pharma and biotech

The scale of pharmaceutical counterfeiting can be staggering to behold – whether in terms of the number of cases, the financial incentives or the economic loss to the legitimate industry.

Analysis

Dust explosion short course at the Wolfson Centre

New hazards: COMAH 2015

The introduction of new COMAH regulations will see many smaller firms affected by the rules for the first time.